Rite Aid’s retail pharmacy segment revenues increased 8.2% over the prior year quarter driven by an extra week in the fourth quarter and an increase in prescriptions.
Of particular importance is the December 2024 extension providing pharmacy clinicians the ability to provide COVID-19 vaccinations, tests and flu shots.
The committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid for treating mild to moderate COVID-19 in adult patients at high risk for progression to severe illness.